Treatment of all stages of Parkinson's disease. Patients with fluctuations related to levodopa plasma concentrations or timing of dose, e.g. end of dose deterioration or wearing-off effects, are more likely to benefit from switching to Madopar CR.
Parkinsonism - idiopathic, post-encephalitic. Previous neurosurgery is not a contra-indication to Madopar. Patients requiring a more rapid onset of action, e.g. patients suffering from early morning or afternoon akinesia, or who exhibit “delayed on” or “wearing off” phenomena, are more likely to benefit from Madopar Dispersible.
Parkinsonism - idiopathic post-encephalitic. Previous neurosurgery is not a contra-indication to Madopar.
Crohn's disease - Induction of remission in patients with mild to moderate active Crohn's disease affecting the ileum and/or the ascending colon. Microscopic colitis - Induction of remission in patients with active microscopic colitis Maintenance of remission in patients with microscopic colitis.